Phase I/II Study of OPB-31121 in Patients With Progressive Hepatocellular Carcinoma

NCT01406574 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

23

Enrollment

INDUSTRY

Sponsor class

Conditions

Hepatocellular Carcinoma

Interventions

DRUG: OPB-31121
DRUG: OPB-31121 phase2

Sponsor

Otsuka Pharmaceutical Co., Ltd.